Skip to main content
Medical information Clinical review pending

Infection Testing

Pneumoslide IgM IFA Test

The Pneumoslide IgM IFA Test helps detect antibodies indicating recent or current respiratory infections caused by various pathogens like Legionella and Mycoplasma. Early diagnosis supports timely treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum (Blood sample)
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Generally, no special preparation is required, but fasting may be requested.
Test priceKSh 11,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Pneumoslide IgM IFA Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Persistent cough
  • ✓Fever
  • ✓Shortness of breath
  • ✓Chest pain
  • ✓Suspected respiratory infection
  • ✓Exposure to respiratory pathogens
  • ✓Compromised immune system
02

In plain language

What this test helps you understand

Detects IgM antibodies to identify recent or current infections caused by various respiratory pathogens, aiding in diagnosis and guiding treatment.
The Pneumoslide IgM IFA Test is a diagnostic tool used to identify specific antibodies in the blood (serum) that suggest a recent or current infection caused by several respiratory pathogens. This test is valuable for pinpointing infections caused by organisms such as Legionella pneumophila, Mycoplasma pneumoniae, and others. Detecting these infections early allows for prompt and effective medical intervention, which can significantly improve patient health outcomes.

This test measures IgM antibodies, which are typically produced early in the course of an infection. The specific pathogens detected include:

- Legionella pneumophila serogroup 1 - Mycoplasma pneumoniae - Coxiella burnetti - Chlamydophila pneumoniae - Adenovirus - Respiratory syncytial virus (RSV) - Influenza A and B - Parainfluenza serotypes 1, 2 & 3

Individuals experiencing symptoms like a persistent cough, fever, difficulty breathing, or chest pain may benefit from this test. People with weakened immune systems or known exposure to respiratory illnesses should also discuss the test with their doctor.

Benefits of this test include early detection of respiratory infections, the ability to identify multiple potential causes simultaneously, and providing information to guide appropriate treatment decisions.

Results indicate the presence or absence of specific antibodies. A positive result suggests a recent or ongoing infection. Discuss your results with your healthcare provider for accurate interpretation and next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Generally, no special preparation is required, but fasting may be requested.
SampleSerum (Blood sample)
MethodologyImmunofluorescence Assay (IFA)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
IgM antibodies may not be detectable in the very early stages of infection. Results must be interpreted in the context of clinical symptoms and other diagnostic findings. Cross-reactivity can occur.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects IgM antibodies in your blood, which indicate a recent or current infection caused by specific respiratory pathogens like Legionella, Mycoplasma, and others.
Individuals with symptoms of a respiratory infection (cough, fever, shortness of breath) or those with risk factors like a weakened immune system should consult their doctor about this test.
A positive result suggests a recent or ongoing infection with one or more of the tested pathogens. Your doctor will interpret the results based on your symptoms and medical history.
Confirm with the laboratory before booking. Usually, no special preparation is needed, but fasting might be requested.
Confirm with the laboratory before booking for the specific turnaround time.
Confirm with the laboratory before booking regarding insurance coverage.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp